Stocks & Investing
Thu, August 8, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 31, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 8, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, April 25, 2024
[ 12:00 AM ] - WOPRAI
Fri, February 16, 2024
[ 12:00 AM ] - WOPRAI
Mon, January 22, 2024
[ 12:00 AM ] - WOPRAI
Thu, November 9, 2023
[ 12:00 AM ] - WOPRAI
Fri, September 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 21, 2023
[ 12:00 AM ] - WOPRAI
Wed, March 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 5, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, May 4, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, April 28, 2022
[ 12:00 AM ] - WOPRAI
Thu, April 21, 2022
[ 12:00 AM ] - WOPRAI
Fri, February 25, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 23, 2022
[ 12:00 AM ] - WOPRAI
Tue, February 8, 2022 Danielle Antalffy Maintained (ZBH) at Strong Sell with Decreased Target to $107 on, Aug 8th, 2024
Danielle Antalffy of UBS, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Strong Sell with Decreased Target from $112 to $107 on, Aug 8th, 2024.
Danielle has made no other calls on ZBH in the last 4 months.
There are 7 other peers that have a rating on ZBH. Out of the 7 peers that are also analyzing ZBH, 5 agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Richard Newitter of "Truist Securities" Maintained at Hold with Decreased Target to $117 on, Tuesday, July 16th, 2024
- Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Decreased Target to $120 on, Monday, July 15th, 2024
- Joanne Wuensch of "Citigroup" Maintained at Hold with Decreased Target to $120 on, Wednesday, July 10th, 2024
- Matthew O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $115 on, Monday, July 1st, 2024
- David Roman of "Goldman Sachs" Initiated at Hold and Held Target at $129 on, Thursday, May 30th, 2024
These are the ratings of the 2 analyists that currently disagree with Danielle
- Matt Miksic of "Barclays" Maintained at Sell with Decreased Target to $125 on, Friday, May 31st, 2024
- David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $150 on, Tuesday, May 21st, 2024
